Pure Global

Prospective Multi-Center Trial for FemBloc Permanent Birth Control - Trial NCT05977751

Access comprehensive clinical trial information for NCT05977751 through Pure Global AI's free database. This phase not specified trial is sponsored by Femasys Inc. and is currently Recruiting. The study focuses on Contraception. Target enrollment is 573 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05977751
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05977751
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control

Study Focus

Contraception

FemBloc

Interventional

device

Sponsor & Location

Femasys Inc.

Columbus,Cincinnati, United States of America

Timeline & Enrollment

N/A

Aug 01, 2023

Jun 01, 2031

573 participants

Primary Outcome

Pregnancy Rate

Summary

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing
 FemBloc followed by ultrasound confirmation test.

ICD-10 Classifications

Contraceptive management
Oral contraceptives
Other contraceptive management
General counselling and advice on contraception
Personal history of contraception

Data Source

ClinicalTrials.gov

NCT05977751

Device Trial